Navigation Links
Depuy 1 Gentamicin Bone Cement

ProductsDepuy 1 Gentamicin Bone Cement
Company DePuy Orthopaedics, Inc.
Item Depuy 1 Gentamicin Bone Cement
Features 
  • Contains 1 gram of gentamicin
  • Homopolymer High Viscosity (more doughy)
  • Quick Setting Time 11 minutes @ 65°F
  • Antibiotic pre-mixed into the cement powder.
  • Proven clinical history.
  • Working time and setting time advantages compared to competition.
  • Description DePuy 1 Gentamicin Bone Cement, a high viscosity antibiotic bone cement, clinically proven in the international market for over a decade, eliminates the inconvenience of mixing an antibiotic into cement. The premixed powder helps to prevent inconsistency in cement-handling characteristics. DePuy 1 Gentamicin Bone Cement provides the same proven characteristics and setting times of the original DePuy 1, with the added benefits of 1 gram of antibiotic.
    Info DePuy Orthopaedics, Inc.
    Customer Service: (800) 366-8143
    Web site: http://www.jnjgateway.com/home.jhtml?loc=USENG&page=viewContent&contentId=09008b9880772d01

    Related medicine products :

    1. Depuy 1 Bone Cement
    2. Depuy 2 Bone Cement
    3. Gentamicin
    4. Gibco Gentamicin Reagent Solution (10 mg/ml) liquid
    5. Gibco Gentamicin Reagent Solution (50 mg/ml), liquid
    6. Gibco Gentamicin Reagent Solution (50 mg/ml) liquid
    7. Gentamicin Sulphate
    8. Gentamicin Sulfate
    9. Gentamicin, 50 mg/ml crimp cap
    10. Gentamicin, 50 mg/ml
    11. Gentamicin, 10 mg/ml
    ... Durable ergonomic chairs with concave seats ... Select options like seats, backrests, armrests, and ... Series for top performance in a variety ... room, static control, health care and office. ...
    ... Durable ergonomic chairs with concave seats ... • Select options like seats, backrests, ... Choose the BE Series for top ... including: industry, education, laboratory, clean room, ...
    ... with concave seats and large backrests ... like seats, backrests, armrests, and casters ... Series for top performance in a ... laboratory, clean room, static control, health ...
    ... with concave seats and large backrests ... like seats, backrests, armrests, and casters ... Series for top performance in a ... laboratory, clean room, static control, health ...
    Medicine Products:
    (Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... its new partnership with the Home Care Association of America (HCAOA). This agreement ... Private Duty Accreditation services, as well as discounts on Accreditation University (AU) educational ...
    (Date:4/28/2017)... ... , ... Beginning in 2017, Ridgecrest Herbals will be phasing out the homeopathic ... Extra Strength formula. To ensure that the effectiveness of Clear Lungs Extra Strength is ... , Removal of the homeopathic element , Adding their patented ...
    (Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. ... GlycoMark test throughout the Northeast U.S. , GlycoMark is the only clinically ... GlycoMark test provides a clinically proven one- to two-week measure of hyperglycemic excursions, ...
    (Date:4/28/2017)... Fairfax, VA (PRWEB) , ... April 28, 2017 , ... ... elected volunteer board members and officers for 2017-2018. The annual board election process has ... serving on a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, ...
    (Date:4/28/2017)... ... , ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical ... Women’s Hospital at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord ... donate. , “Women’s Hospital at Renaissance has been a collection partner for the ...
    Breaking Medicine News(10 mins):
    (Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
    (Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
    (Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
    Breaking Medicine Technology: